Today: 1 May 2026
Spain Stock Market Today (10 Nov 2025): IBEX 35 Reclaims 16,000 on U.S. Shutdown Hopes; Almirall, Rovi & IAG Lead
10 November 2025
3 mins read

Spain Stock Market Today (10 Nov 2025): IBEX 35 Reclaims 16,000 on U.S. Shutdown Hopes; Almirall, Rovi & IAG Lead

Madrid, 10 November 2025 (mid‑session update). Spain’s blue‑chip IBEX 35 is trading firmly higher, back above 16,000 and hovering near 16,100 as risk appetite improves on signs the historic U.S. government shutdown could soon end. As of early afternoon, the index was up roughly +1.3% around 16,108, after opening at 16,074; today’s intraday range has stretched between ~16,042 and ~16,127. The previous close was 15,901, and the 52‑week range runs 11,295–16,210.5.


Market at a glance (as of ~12:15–12:30 CET)

  • IBEX 35: ~16,108, +1.3%; regained the 16,000 handle on broad European strength.
  • Backdrop: European equities climbed as the U.S. Senate advanced a bill that would reopen the federal government, lifting sentiment across global markets. The STOXX 600 gained about 1.1% in morning trade.
  • Macro pulse: Eurozone Sentix investor confidence weakened to ‑7.4 in November (vs. ‑5.4 in October), a reminder that growth headwinds linger even as risk assets bounce.
  • FX & commodities:EUR/USD is near 1.155, Brent crude around $64, and gold above $4,000 an ounce, reflecting a modest “risk‑on” tone with safe‑haven support. Reuters
  • Local note: Trading is open despite a local holiday in Madrid (La Almudena) being observed today in the capital.

What’s driving Spanish stocks today

1) Washington developments are easing nerves. Progress toward ending the 40‑day U.S. government shutdown has brightened the global outlook, fueling a rebound across Europe and helping the IBEX reclaim the psychologically important 16,000 level. European benchmarks rose 1%+ in early dealings as investors priced in the prospect of U.S. data and policy visibility returning.

2) Domestic movers are doing the heavy lifting. A cluster of Spain‑listed names is outperforming at midday, supporting headline index gains.


Big movers on the IBEX 35 (mid‑session)

  • Laboratorios Rovi: up roughly 3–4%, aided by positive sentiment around healthcare and read‑across from peer newsflow.
  • IAG (Iberia parent): +3–4% after supportive broker commentary—JPMorgan reiterates Overweight with a €5.50 price target and upbeat Q4 expectations.
  • Solaria: +3–4%, as renewables catch a bid in the risk‑on session.
  • Banks (Santander, BBVA): firmer; Santander trades around the €9 mark after recent strength, adding backbone to the index.
  • Telefónica: a laggard again today, still digesting last week’s dividend cut and new strategy that knocked shares sharply lower.

Note: In late October the IBEX set a new record high, surpassing its 2007 peak—today’s rebound keeps the index within sight of those levels.


Company headlines shaping the session (10 Nov 2025)

  • Almirall surges on 9M results & guidance confirmation. The Barcelona‑based pharma reported 9‑month net sales growth of ~12.8%, EBITDA ~€180.7m, and reaffirmed FY2025 guidance (net sales +10–13%, EBITDA €220–240m). Shares jumped on the update, making Almirall one of the morning’s standout risers on Spain’s market coverage.
  • Oryzon Genomics plans a capital increase of up to €125m. The biotech convened an extraordinary shareholder meeting to approve the issuance, a move that weighed on the stock on the continuous market.
  • Brokerage color:JPMorgan reiterated Overweight on IAG (PT €5.50), while other houses provided incremental moves across Spanish large caps (e.g., Inditex referenced with a €49 PT in sector work).

Macro cross‑currents to watch

  • Eurozone sentiment: The Sentix November print at ‑7.4 (worse than expected) underscores a fragile backdrop even as equities rally on U.S. headlines.
  • Data calendar: In Europe, attention turns to euro‑area GDP readings later this week; globally, investors remain focused on the U.S. policy path as Washington’s funding resolution progresses.

Why it matters for investors

Spain’s market leadership in 2025—capped by the IBEX’s October record—has been underpinned by banking strength, resilient domestic consumption, and index heavyweights executing well. Today’s risk‑on session keeps the benchmark within striking distance of its highs, while fresh corporate catalysts (Almirall’s results, broker calls) and macro clarity from the U.S. set the tone into the close.


Key levels & context (SEO quick hits)

  • Spain stock market today (10.11.2025): IBEX ~16,108 (+1.3%) at mid‑session; day range 16,042–16,127; prior close 15,901; 52‑week high 16,210.5.
  • Top stories affecting Spanish shares today: U.S. shutdown progress; Almirall 9M results; Oryzon capital plan; broker support for IAG; banks firm.
  • Local color:Madrid’s La Almudena holiday reduces on‑the‑ground activity in the capital, though the exchange remains open.

Data and developments cited above reflect conditions reported through early afternoon on Monday, 10 November 2025. Figures may update by the closing bell.

Sources: Reuters live market pages and European market wrap; Cinco Días real‑time market blog and company reports; El Español Invertia live blog; Estrategias de Inversión midday update; company press releases and investor pages.

Stock Market Today

  • Jefferies Boosts Great-West Lifeco (TSE:GWO) Price Target to C$83, Citing 12.76% Upside
    May 1, 2026, 3:38 PM EDT. Jefferies Financial Group raised its price target for Great-West Lifeco (TSE:GWO) from C$70.00 to C$83.00, signaling a 12.76% potential gain. Other analysts like Royal Bank of Canada and Barclays also increased their targets, reflecting growing confidence. The stock trades at C$73.61 amid a 12-month high near C$73.87, with a moderate buy consensus and average target of C$71.30. Great-West Lifeco reported quarterly earnings of C$1.36 per share and revenue of C$8.34 billion. Insider selling occurred recently, with 70.7% of shares held by insiders. The firm shows a strong return on equity (13.98%) and maintains healthy liquidity ratios. The latest upgrades underline bullish sentiment for this insurance and financial services company listed on the Toronto Stock Exchange.

Latest article

Newell Brands Stock Jumps After 2026 Outlook Hike, But the Sales Test Is Not Over

Newell Brands Stock Jumps After 2026 Outlook Hike, But the Sales Test Is Not Over

1 May 2026
Newell Brands raised its 2026 sales and earnings outlook after first-quarter results beat expectations, sending shares up about 9% to $4.445. Net sales fell 1.1% to $1.549 billion, but gross margin improved to 33.1%. The company now expects 2026 net sales to be flat to up 2%, compared to its previous forecast of down 1% to up 1%. Core sales dropped 3.5% in the quarter.
nVent Stock Jumps After Data-Center Demand Triggers a 2026 Forecast Reset

nVent Stock Jumps After Data-Center Demand Triggers a 2026 Forecast Reset

1 May 2026
nVent Electric raised its 2026 sales and profit forecasts after first-quarter net sales jumped 53% to $1.24 billion and adjusted EPS climbed 63% to $1.09. Organic orders rose about 40% and backlog hit $2.6 billion, driven by data-center demand for liquid cooling and power equipment. Shares surged 13.3% to $161.94, pushing market value to $26.5 billion. The company now expects full-year sales growth of up to 28%.
SoundHound AI Stock Jumps Before May 7 Earnings As Investors Test The AI Growth Story

SoundHound AI Stock Jumps Before May 7 Earnings As Investors Test The AI Growth Story

1 May 2026
SoundHound AI shares rose about 17% to $9.31 in Friday afternoon trading ahead of its May 7 first-quarter earnings report. Investors are watching for signs that recent deals, including the planned $43 million acquisition of LivePerson and an expanded rollout with Casey’s General Stores, can drive growth. SoundHound posted 2025 revenue of $168.9 million but reported a full-year GAAP net loss of $14 million.
FTSE 100’s Record Run: Inside London’s Blue-Chip Rally and What’s Next
Previous Story

FTSE 100 Jumps on US Shutdown Hopes as Diageo Soars; BoE Stablecoin Plan and Gold Rally Lift London Stocks — UK Market Wrap (10 November 2025)

Stocks to Watch Today (Nov. 10, 2025): Nvidia Rebounds; Pfizer Clinches Metsera; Novo Nordisk Rises; Rumble Soars on AI Deal; Tyson Foods Guides Higher
Next Story

Stocks to Watch Today (Nov. 10, 2025): Nvidia Rebounds; Pfizer Clinches Metsera; Novo Nordisk Rises; Rumble Soars on AI Deal; Tyson Foods Guides Higher

Go toTop